Porfiromycin: Clinical Trials

4 trials of Porfiromycin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated. 3 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 33Completed 2, Terminated 1
Phase 11Terminated 1

Follow Porfiromycin: new trials by email Literature Review of Porfiromycin trials Research Report on Porfiromycin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Porfiromycin Used as an Adjuvant to Radiation Therapy in Postoperative Head and Neck Cancer Patients
Porfiromycin, Placebo, Radiotherapy - Head and Neck Neoplasms
Phase 3TerminatedBoehringer Ingelheim32000-05-012014-07-08
Pharmacokinetic Study of Porfiromycin in Head and Neck Cancer and Other Cancer Patients With Solid Tumors
Porfiromycin - Head and Neck Neoplasms
Phase 1TerminatedBoehringer Ingelheim31999-12-012014-08-06
Radiation Therapy Plus Porfiromycin in Treating Patients With Stage III or Stage IV Head and Neck Cancer
porfiromycin, radiation therapy - Head and Neck Cancer
Phase 3CompletedBoehringer Ingelheim6001997-12-012010-05-21
Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer
mitomycin C, porfiromycin, brachytherapy - Carcinoma of Unknown Primary, Head and Neck Cancer
Phase 3CompletedYale University1992-11-012013-07-25

Conditions studied

Head and Neck Neoplasms (4)  ·  Squamous Cell Carcinoma of Head and Neck (2)  ·  Neoplasms, Unknown Primary (1)

Sponsors

Boehringer Ingelheim (3)  ·  Yale University (1)

Countries

United States (2)

Top investigators

James J. Fischer, MD, PhD (1)  ·  Peter M. Glassman, MD, PhD (1)